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Abstract
Clostridium difficile is a Gram-positive spore-forming anaerobe and a major cause of antibi-
otic-associated diarrhoea. Disruption of the commensal microbiota, such as through treat-
ment with broad-spectrum antibiotics, is a critical precursor for colonisation by C. difficile
and subsequent disease. Furthermore, failure of the gut microbiota to recover colonisation
resistance can result in recurrence of infection. An unusual characteristic of C. difficile
among gut bacteria is its ability to produce the bacteriostatic compound para-cresol (p-cre-
sol) through fermentation of tyrosine. Here, we demonstrate that the ability of C. difficile to
produce p-cresol in vitro provides a competitive advantage over gut bacteria including
Escherichia coli, Klebsiella oxytoca and Bacteroides thetaiotaomicron. Metabolic profiling of
competitive co-cultures revealed that acetate, alanine, butyrate, isobutyrate, p-cresol and p-
hydroxyphenylacetate were the main metabolites responsible for differentiating the parent
strain C. difficile (630Δerm) from a defined mutant deficient in p-cresol production. More-
over, we show that the p-cresol mutant displays a fitness defect in a mouse relapse model
of C. difficile infection (CDI). Analysis of the microbiome from this mouse model of CDI dem-
onstrates that colonisation by the p-cresol mutant results in a distinctly altered intestinal
microbiota, and metabolic profile, with a greater representation of Gammaproteobacteria,
including the Pseudomonales and Enterobacteriales. We demonstrate that Gammaproteo-
bacteria are susceptible to exogenous p-cresol in vitro and that there is a clear divide
between bacterial Phyla and their susceptibility to p-cresol. In general, Gram-negative spe-
cies were relatively sensitive to p-cresol, whereas Gram-positive species were more toler-
ant. This study demonstrates that production of p-cresol by C. difficile has an effect on the
viability of intestinal bacteria as well as the major metabolites produced in vitro. These
observations are upheld in a mouse model of CDI, in which p-cresol production affects the
biodiversity of gut microbiota and faecal metabolite profiles, suggesting that p-cresol pro-
duction contributes to C. difficile survival and pathogenesis.
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Author summary
Clostridium difficile is a bacterium responsible for causing the majority of antibiotic asso-
ciated diarrhoea outbreaks world-wide. In the United States of America, C. difficile infects
half a million people annually. Antibiotics disrupt the natural protective gut microbiota,
rendering people susceptible to C. difficile infection, which leads to potentially life-threat-
ening disease and complications. C. difficile is transmitted by spores, which are able to sur-
vive in harsh environments for long periods of time. After initial treatment for C. difficile,
up to 35% of patients develop the disease again, thus requiring additional and more suc-
cessful treatment. Here, we use novel techniques to show that C. difficile produces a com-
pound, p-cresol, which has detrimental effects on the natural protective gut bacteria. We
show that p-cresol selectively targets certain bacteria in the gut and disrupts their ability to
grow. By removing the ability of C. difficile to produce p-cresol, we show that it makes C.
difficile less able to recolonise after an initial infection. This is linked to significant alter-
ations in the natural healthy bacterial composition of the gut. Our study provides new
insights into the effects of p-cresol production on the healthy gut microbiota and how it
contributes to C. difficile survival and pathogenesis.
Introduction
Clostridium difficile is a Gram-positive spore-forming enteric pathogen and the leading cause
of antibiotic-associated diarrhoea worldwide[1]. C. difficile infection (CDI) ranges from self-
limiting diarrhoea to severe and life threatening pseudomembranous colitis[2]. C. difficile
spores are the aetiological agent of CDI transmission and are resistant to desiccation, environ-
mental stress, disinfectants and heat[3, 4]. These spores, present in both hospitals and the envi-
ronment are transmitted via the faecal-oral route, contributing to both nosocomial and
community acquired CDI [3]. Infection with C. difficile is frequently preceded by treatment
with broad-spectrum antibiotics, which eliminate discrete taxa of the commensal intestinal
microbiota resulting in dysbiosis and permitting colonisation by C. difficile. Certain bacterial
taxa have been highlighted as important in the prevention of C. difficile colonisation[5–7].
Since restoration of microbial diversity can resolve recurrent infections, faecal transplantation
is viewed as an effective treatment strategy[8]. However, a greater understanding of how C. dif-
ficile is able to influence the gut microbiota and disrupt intestinal homeostasis is a current
imperative.
Human intestinal bacteria have been shown to ferment dietary-derived carbohydrates[9]
and proteins[10], producing short chain fatty acids (SCFA), as well as an array of metabolites
via fermentation of aromatic amino acids[11]. The secondary metabolites of this highly diverse
microbial community have the potential to either positively or negatively influence many
aspects of human health [12], with some demonstrated to possess toxic and carcinogenic prop-
erties [11, 13, 14]. Aromatic amino acids such as phenylalanine, tryptophan and tyrosine are
important sources of phenyl metabolites. These metabolites can be absorbed in the small intes-
tine or pass through to the colon[15] to be excreted in faeces. One such fermentation product,
phenylacetic acid (PAA), is the most commonly detected secondary metabolite in healthy
human faeces, with reported concentrations of 479 μM[15]. C. difficile ferments tyrosine, via
p-hydroxyphenylacetate (p-HPA), to produce p-cresol. Para-cresol is a phenolic compound
[16] that has been demonstrated to inhibit the growth of a range of bacterial species and other
microorganisms[17, 18]. To date, the capacity to produce p-cresol has only been demonstrated
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in a select number of organisms[19, 20], including eighteen intestinal commensal species[11].
However, the in vitro production of p-cresol by these species was relatively low (ranging from
0.06–1.95 μg/ml)[11]. Furthermore, C. difficile can tolerate relatively high concentrations (1
mg/ml) of p-cresol[21, 22]. As such, the ability to synthesise and tolerate high concentrations
of p-cresol has led to the hypothesis that it may provide C. difficile with a competitive advan-
tage over other microorganisms.
The enzyme responsible for the decarboxylation of p-HPA is a member of the glycyl radical
family, 4-hydroxyphenylacetate decarboxylase, which is encoded by three genes hpdB
(CD630_01530),hpdC (CD630_01540)and hpdA (CD630_01550), which are co-transcribed in
an operon. The hpdBCA operon is highly conserved in all the sequenced C. difficile isolates.
We have previously shown that disruption of any of the three genes renders C. difficile incapa-
ble of synthesising p-cresol[22]. In this study, we demonstrate that production of p-cresol by
C. difficile confers a fitness advantage over other intestinal bacteria both in vitro and in vivo,
specifically those with a Gram-negative cell envelope. The treatment of human faecal samples
with exogenous p-cresol significantly modified the cultivable bacteria therein, in a species-spe-
cific manner. Furthermore, a p-cresol deficient mutant showed a modest but significant reduc-
tion in viable counts in a relapse mouse model of CDI. Comparisons of the metabolic and 16S
rRNA profiles identified variation in the biochemical and bacterial composition between mice
infected with the C. difficile strain 630Δerm and the p-cresol deficient mutant (hpdC::CT) fol-
lowing infection and relapse. This is the first study to show that p-cresol production is a mech-
anism by which C. difficile confers a competitive advantage over other gut bacteria.
Results
Exogenous p-cresol inhibits the growth of Gram-negative intestinal
commensal bacteria
It has been hypothesised that p-cresol production provides C. difficile with a selective advan-
tage over competitors in the human gut. To investigate this, we assessed the effect of exogenous
p-cresol on the in vitro growth dynamics of selected intestinal commensal species (S1 Table)
compared to C. difficile strain 630Δerm (Fig 1 & S2 Table). The data shows a clear pattern
whereby sensitivity to p-cresol correlated with bacterial cell envelope structure. We observed
that Gram-positive bacteria were significantly more tolerant to p-cresol than Gram-negative
bacteria (Coefficient of variance (COV) = 0.599, p<0.001). Growth of the Gram-negative spe-
cies, including members of the Bacteroidaceae (Bacteroides thetaiotaomicron) and Enterobac-
teriaceae (Escherichia coli, Klebsiella oxytoca and Proteus mirabilis) families were inhibited by
the addition of exogenous p-cresol in a dose-dependent manner (Fig 1 & S3 Table) and dem-
onstrated a significant decrease in cell growth compared to C. difficile (p<0.005). In contrast,
the Gram-positive species including those from the Bifidobacteriaceae (Bifidobacterium adoles-
centis), Enterococcaceae (Enterococcus faecium) and Lactobacillaceae (Lactococcus fermentum)
families displayed no significant reduction in growth rate, even at 0.1% (v/v) p-cresol (Fig 1).
Interestingly, E. faecium displayed greater tolerance to p-cresol than C. difficile itself
(COV = 0.6 p = 0.002, S3 Table).
We had previously constructed a ClosTron inactivation mutant in the hpdC decarboxylase
gene (strain hpdC::CT), which renders C. difficile unable to produce p-cresol[22]. To investi-
gate whether production of p-cresol contributes to fitness in vitro, we performed co-culture
assays with 630Δerm and hpdC::CT cultured with a selection of intestinal commensal species,
supplemented with exogenously added p-cresol. Brain heart infusion media with yeast extract
(BHIS) was chosen for these co-culture experiments, as we have previously shown that intrin-
sic production of p-cresol under these conditions is negligible[22], therefore any observed
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Fig 1. Growth of gut commensals in medium supplemented with exogenous p-cresol. Growth of gut commensals in
BHIS compared to media containing 0.01%, 0.5% and 0.1% (v/v) p-cresol. Each curve represents the mean growth rate
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effect could be attributed to the exogenously added p-cresol. We observed no difference in
growth rate between 630Δerm and hpdC::CT in these conditions [22]. To establish the compa-
rable growth conditions, each species was normalised to the same starting optical density
(OD595 0.5) and starting CFU/ml was determined (S4 Table). The competitors were mixed in a
1:1 ratio at matched OD, and were grown for 24 hours in media supplemented with 0.05% (v/
v) p-cresol. Viable counts for each species were determined by plating serial dilutions onto
media supplemented with and without D-cycloserine and cefoxitin, facilitating differentiation
between C. difficile and the competitor. When C. difficile 630Δerm was grown in co-culture
with E. coli in the absence of exogenous p-cresol, E. coli was the dominant organism, repre-
sented by a significantly higher CFU/ml than C. difficile (8:1 ratio of E. coli to C. difficile)
(COV = 1.02, p = 0.003; Fig 2, S5 Table). However, when the medium was supplemented with
exogenous p-cresol, the relative proportion of C. difficile increased to a ratio of 1:1, represent-
ing an 8-fold increase in the number of viable C. difficile (Fig 2A) (COV = -1.38, p<0.001). A
similar profile was observed when E. coli was co-cultured with the hpdC::CT mutant (Fig 2B)
(COV = -0.27, p = 0.882). This suggests that 630Δerm and the hpdC::CT mutant displayed
comparable fitness when grown in co-culture with E. coli. When C. difficile was grown in co-
culture with a Gram-positive bacterium, E. faecium, C. difficile was significantly less abundant
compared with the competitor (COV = 3.41, p<0.001). Here, we observed a ratio of 1:10 of C.
difficile to E. faecium (Fig 2C & S5 Table). The growth dynamics of the C. difficile hpdC::CT
mutant and E. faecium (Fig 2D) were also indistinguishable from the 630Δerm grown in
competition with E. faecium (COV = -0.33, p = 0.283). However, when the medium was
supplemented with p-cresol, the relative proportion of E. faecium increased significantly
(COV = 1.44, p = 0.010). This suggests that the growth conditions were more permissive for
E. faecium. However, this was not the case for all Gram-positive species tested. The relative
ratio in co-culture of C. difficile (630Δerm and hpdC::CT mutant) to L. fermentum was not sig-
nificantly altered by exogenous p-cresol (COV = -0.058, p = 0.818) (Fig 2E & 2F and S5 Table).
These data indicate that p-cresol had a range of effects on growth dynamics depending on the
Phylum of bacteria and their susceptibility to p-cresol.
Intrinsic production of p-cresol gives C. difficile a competitive growth
advantage in vitro
We observed no difference in competitive fitness between wild type and p-cresol mutant when
grown in BHIS supplemented with 0.5% (w/v) p-cresol. Therefore, we developed an additional
in vitro competition assay to determine whether intrinsic p-cresol production by C. difficile
conferred a competitive advantage over other intestinal commensal species. To achieve this we
measured the growth rate of E. coli and K. oxytoca in monoculture and compared this to that
of C. difficile (S1A Fig). Under these conditions, C. difficile reached exponential growth at a
later time point than the other species tested. Furthermore, we have previously shown that p-
cresol is detected in C. difficile cultures at around 4 hours (or OD595 0.5) [22]. In order to limit
the dominance of competitor species, and ensure optimal p-cresol production, we grew C. dif-
ficile to exponential phase (OD595 0.6) before inoculating the medium with the competitor (at
OD595 0.05). We also supplemented the growth medium with p-HPA to drive production of p-
cresol. To determine a concentration of p-HPA that resulted in inhibitory p-cresol production,
competitive co-culture experiments with C. difficile and E.coli were performed in a range of p-
of three independent replicates. Regression analysis was used to determine significant differences in growth rate
compared to the BHIS control over the course of the experiment and marked  p<0.01. Error bars represent the
standard deviation.
https://doi.org/10.1371/journal.ppat.1007191.g001
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HPA concentrations (0.1%, 0.2% or 0.3% (w/v)) (Fig 3). When the medium was supplemented
with 0.1% (6.5 mM) p-HPA we observed a ratio of 13:1 (E. coli:C. difficile) (Fig 3A). When the
Fig 2. Co-culture assays in medium supplemented with exogenous p-cresol. Relative fitness of C. difficile 630Δerm and hpdC::CT when grown in co-culture with
gut commensals, with and without 0.05% (v/v) p-cresol. The relative fitness of 630Δerm and hpdC::CT grown in co-culture with a&b) E. coli, c&d) E. faecium, e&f) L.
fermentum (e&f). Viable counts are represented by CFU/ml and displayed as a percentage of the total culture. Error bars are representative of three independent
replicates. Regression analysis was used to determine significant differences in growth taking strain and media into consideration p<0.001.
https://doi.org/10.1371/journal.ppat.1007191.g002
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concentration of p-HPA was increased to 0.2% (13.1 mM), we observed a significant difference
(p<0.001) in the ratio of E. coli: C. difficile (1:1), compared to the ratio in 0.1% p-HPA (13:1)
(Fig 3A). Further increasing the concentration of p-HPA to 0.3% (19.7 mM) resulted in culture
conditions that favoured C. difficile, reflected by a ratio of 1:4 (E. coli:C. difficile) (p<0.001)(Fig
3A). Thus, we observed a positive correlation between the proportion of p-HPA supplemented
in the growth medium and the survival of C. difficile compared to E. coli (Fig 3A). To deter-
mine whether this effect was linked to the level of p-cresol production, we quantified p-cresol
in these culture supernatants by High Performance Liquid Chromatography (HPLC) (Fig 3B).
Fig 3B demonstrates that increasing p-HPA concentration correlated with a significant
increase in p-cresol production (p<0.001). We observed 25 ±0.04 mM p-cresol when the
growth medium was supplemented with 0.3% p-HPA (Fig 3B).
Next, we investigated whether the p-cresol mutant displayed reduced fitness when grown in
competitive co-culture with other gut competitor species. Furthermore, we constructed a com-
plement by expressing the hpdC and hpdA genes from a tetracycline-inducible promoter using
a plasmid based system (generating strain hpdC::CT::phpdCA). We compared the growth of C.
difficile strains 630Δerm, hpdC::CT and the complement (hpdC::CT::phpdCA), in competition
with E. coli, K. oxytoca or B. thetaiotaomicron in media supplemented with 0.2% p-HPA (Fig
4). The number of viable counts for each species was determined as outlined above. When
630Δerm was grown in co-culture with E. coli, we observed a 1:1 ratio of C. difficile to E. coli
(Figs 4A & 3A). This was consistent with the co-culture assays supplemented with exogenous
p-cresol (Fig 2). However, competitive co-culture between hpdC::CT and E. coli resulted in a
decrease in the relative proportion of C. difficile to ca. 25% of the total culture (1:4, C. difficile:
E. coli). This indicates that the mutant was significantly less viable than the wild type (COV =
-1.06, p<0.001). 630Δerm demonstrated comparable relative fitness in competitive co-culture
with K. oxytoca (1:1 ratio) (Fig 3B). However, we observed proportionally fewer CFUs of
630Δerm when grown in co-culture with B. thetaiotaomicron (1:4 ratio) (Fig 3C). By contrast,
hpdC::CT displayed reduced fitness relative to 630Δerm when grown in competition with both
K. oxytoca (COV = -1.40, p<0.001) and B. thetaiotaomicron (COV = -0.79, p = 0.001). This fit-
ness defect was restored when the complement was grown in competition with K. oxytoca and
B. thetaiotaomicron (Fig 3). However, complementation of the hpdC mutation, did not restore
Fig 3. The effect of p-HPA supplementation on competitive co-culture of C. difficilewith E. coli and detection of
p-cresol production. a) A comparison of the percentage survival of C. difficile strain 630Δerm and E. coli in
competitive co-culture for 24 hours, performed in 0.1%, 0.2% and 0.3% p-HPA. Statistical difference in percentage
survival was calculated using regression analysis taking strain and media into consideration p<0.001. b) HPLC
quantification of p-cresol production in competitive co-culture of C. difficile strain 630Δermwith E. coli in media
supplemented with 0.1%, 0.2% and 0.3% p-HPA. Statistical difference in p-cresol production was calculated using a
two tailed t-test with Welch’s correction, comparing individual p-cresol concentrations to the level produced in 0.1%
p-HPA p<0.001.
https://doi.org/10.1371/journal.ppat.1007191.g003
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C. difficile fitness to wild-type levels in competitive co-cultured with E. coli. Therefore, we
quantified both p-cresol production and p-HPA utilisation by HPLC (Figs 4D, 3B & S2).
Quantification of 630Δerm supernatants grown in both monoculture and competitive co-cul-
ture supplemented with 0.2% p-HPA revealed an average p-cresol concentration of 13.3 ±0.1
mM. In contrast, the concentration in supernatants of the complemented mutant (at 0.2%
p-HPA) was only 4.8 ±0.2 mM, representing a significant 2.7 fold reduction (p<0.01). There-
fore, we conclude that under competitive co-culture conditions, 4.8 ±0.2 mM p-cresol was suf-
ficient to have a deleterious effect on the growth of K. oxytoca and B. thetaiotaomicron, but not
on E. coli. Increasing the concentration of the transcriptional inducer (anhydrotetracycline)
and p-HPA resulted in increased p-cresol production (from 4.8 ±0.2 mM to 15.6 ±3.9 mM) by
the complement and restoration of the phenotype (S2 Fig). Here, the level of p-cresol produc-
tion directly correlated with the concentration of the transcriptional inducer (S2C and S2D
Fig). As expected, this suggests that complementation was more greatly influenced by tran-
script expression rather than availability of the p-HPA precursor. Furthermore, we observed
Fig 4. Competition co-culture assays in the presence of endogenous p-cresol. Relative fitness of C. difficile strains 630Δerm,
hpdC::CT and the complement hpdC::CT::phpdC-A were grown in competitive co-culture for 24 hours with gut commensal
species a) E.coli, b) K. oxytoca and c) B. thetaiotaomicron. The growth medium was supplemented with the intermediate in the p-
cresol pathway, pHPA (at 0.2% v/v) and 50 ng/ml anhydrotetracycline to induce expression of hpdCA, encoded in trans. The
relative representation of each strain was expressed as a percentage of the total CFU count. Error bars are representative of three
independent replicates and show the variation across replicates and co-culture conditions. Regression analysis was used to
determine significant differences in growth taking strain into consideration and marked  p<0.01 and p<0.001. d) The
concentration of p-cresol produced in the co-cultures of three independent replicates was quantified by HPLC and plotted in
GraphPad Prism7. Statistical analysis was performed by Linear regression, significant differences in p-cresol production
compared to 630Δerm are indicated  p<0.001.
https://doi.org/10.1371/journal.ppat.1007191.g004
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no difference in growth rate between the three C. difficile strains at any tested concentration of
anhydrotetracycline (S1 Fig). Taken together, these data suggest that production of p-cresol by
C. difficile confers a competitive growth advantage over susceptible bacterial species (specifi-
cally, Gram-negative species) under our in vitro conditions.
Metabolic profiling of C. difficile and the intestinal commensal species
To further understand the effect of p-cresol production on the interaction between C. difficile
and these intestinal species, we characterised the metabolic content of both mono-culture and
competitive co-culture supernatants using 1H nuclear magnetic resonance (NMR) spectros-
copy. We analysed the culture supernatants described in Fig 4 and performed principal com-
ponent analysis (PCA) to identify metabolic variation across the profiles. The scores plot from
the PCA model comparing all profiles showed that the largest variation in the metabolic data
(Principal Component 1 (PC1)) was between the C. difficile strain 630Δerm samples and those
from the hpdC::CT strain (Fig 5A). The metabolic profiles from the complement samples clus-
tered between 630Δerm and hpdC mutant samples. The loadings for PC1 describe the metabo-
lites varying between the strains. This indicated that culture supernatants from 630Δerm
contained significantly greater amounts of p-cresol and alanine compared to the other strains,
but lower amounts of p-HPA, butyrate and isobutyrate (Fig 5B). This was consistent with the
Fig 5. Metabolic profiling of C. difficile in monoculture and competitive co-culture with intestinal commensal species. a) Principle component analysis (PCA) score
plot based on the 1H NMR spectra of the three C. difficile strains (630Δerm (black), hpdC::CT (red) and the complemented mutant (hpdC::CT::phpdC-A) in (blue), grown
in monoculture (circle symbol) or in competitive co-culture with intestinal commensal species, E. coli (square), K. oxytoca (triangle) and B. thetaiotaomicron (star), in
BHIS media supplemented with 0.2% p-HPA. b) Metabolite clustergram represented as a heatmap of Z-scores of the 1H NMR peak integrals, derived from the quantity of
six main metabolites driving the separation between the samples (observed on the loading plots of the model) and a dendrogram showing the hierarchical clustering of the
samples. The culture conditions, bacterial strains and p-HPA concentration are colour coded in a key on the heatmap.
https://doi.org/10.1371/journal.ppat.1007191.g005
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notion that p-HPA is being depleted in order to produce p-cresol. The 630Δerm samples clus-
tered together regardless of whether the bacteria were grown in mono-culture or co-cultured
with E. coli, K. oxytoca or B. thetaiotaomicron. In contrast, hpdC::CT and complement (hpdC::
CT::phpdC-A) strains were separated in the second principal component (PC2) based on the
competitive co-culture conditions. The loadings for PC2 indicated that the mono-cultured C.
difficile and B. thetaiotaomicron competitive co-culture samples contained lower amounts of
acetate compared to the competitive co-cultures from E.coli and K. oxytoca. This metabolic
variation between strains and competitive co-culture conditions is summarised in the cluster-
gram shown in Fig 5B, which was constructed from the Z-scores of 1H NMR peak integrals
measured for each metabolite across all samples. The dendrogram shows that the 630Δerm
metabolic profiles clearly cluster away from those of the other two strains (Fig 5) and the varia-
tion in p-cresol production between samples is apparent in the 1H NMR spectrum (S3 Fig).
The dendrogram also showed that p-cresol and alanine clustered together as did butyrate and
isobutyrate (Fig 5B). We also assessed the effect of altered p-HPA concentration on metabolic
profiles. The PCA of metabolites produced in media supplemented with 0.1% and 0.2% p-
HPA demonstrated no clear metabolic variation between these samples. However, we did
observe clustering within the 0.1% p-HPA samples, driven by increased p-cresol and alanine
(S4 Fig). These data suggest that under these growth conditions p-cresol is one of the most
abundant metabolites in culture supernatants. This is reflected by both metabolic profiling and
HPLC quantification, which correlates to p-cresol susceptibility observed in both competitive
co-culture and monoculture of Gram-negative bacteria.
Mouse relapse model of C. difficile infection
Our results have demonstrated that p-cresol production confers a fitness advantage over dis-
crete bacterial species in vitro. Therefore, we sought to determine whether this was also true in
vivo. Individually caged C57BL/6 mice were infected in parallel with 1x104 spores of C. difficile
strain 630Δerm (n = 5) or the hpdC::CT mutant (n = 5) and compared to uninfected naïve con-
trol mice (n = 5), in a relapse model of infection. Mice were given cefoperazone in their drink-
ing water for 10 days to stimulate gut dysbiosis, before infection by oral gavage with C. difficile
spores (Fig 6A)[23, 24]. Stool samples were collected throughout the experiment for analysis.
Twenty-eight days post-infection, mice were treated with vancomycin in their drinking water
for 7 days to encourage recurrence of infection (Fig 6A). Infection was monitored by enumera-
tion of spores isolated from faeces on C. difficile selective media (Fig 6B). We observed no sig-
nificant difference in the number of spores recovered from faeces of mice infected with either
630Δerm or hpdC::CT following cefoperazone treatment, indicating that the hpdC::CT mutant
and 630Δerm were equally competent at initial colonisation (Fig 6C). This was consistent with
the notion that these strains demonstrate similar resistance to cefoperazone and vancomycin
(S6 Table) and no differences in sporulation in vitro (S5 Fig). However, at day 7 post-infection
we observed a modest difference in colonisation, represented by significantly fewer 630Δerm
CFUs compared to the hpdC::CT mutant (p<0.05). Relapse was detected by enumeration of C.
difficile spores post-vancomycin treatment. Three days following removal of vancomycin
(D3R), spores were detected in all but one 630Δerm infected mouse and three out of five
hpdC::CT mutant infected mice. By day 4 post-relapse (D4R) C. difficile spores were recovered
from the faeces of all mice and we observed a significant reduction (p<0.05) in the number of
spores recovered from the faeces of mice infected with the hpdC::CT mutant relative to
630Δerm infected mice (Fig 6D). Both infections followed a broadly comparable progression,
however, we observed modest but significant differences in the number of spores recovered
both pre- and post- relapse between 630Δerm infected and hpdC::CT infected mice at discrete
Para-cresol production by Clostridium difficile affects microbial diversity
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007191 September 12, 2018 10 / 31
Fig 6. Infection of mice with 630Δerm and hpdC::CT. a) A schematic of the C. difficile relapse infection in C57BL/6 mice. b) CFU counts enumerated
from the faeces of individually caged animals (n = 5) infected with either wild-type C. difficile strain (630Δerm) or the corresponding p-cresol null
mutant (hpdC::CT) over the duration of the primary infection (days 1–21) and relapse (days 1R-7R). c) CFU enumerated from the faeces day 4 post-
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time points. Interestingly during relapse, the spore density remained lower in hpdC::CT com-
pared to 630Δerm, despite an initially higher CFU at D7 post-infection, indicating that these
differences are a result of in vivo fitness.
Composition of the intestinal microbiota
Given that the hpdC::CT mutant displayed an altered colonisation profile during relapse and
that p-cresol displays bacteriostatic properties against a number of species, this led us to postu-
late that production of p-cresol may alter the composition of the intestinal microbiota in such
a way that favoured C. difficile re-colonisation. We isolated bacterial DNA from four key time
points during the relapse model of CDI; day 7 post-cefoperazone treatment, immediately upon
cessation of vancomycin treatment (D0R), day 2 post-relapse (D2R) and day 4 post-relapse
(D4R), when all the mice were colonised with C. difficile (1.6 x 106 WT and 2.3 x 105 hpdC::CT
mutant spores/g faeces). To assess the community structure of the microbiota, 16S rRNA
sequencing was performed by sequencing the V5-V7 region of 16S rRNA gene. The data was
grouped with distance-based similarity of 97% into operational taxonomic units (OTUs),
using Greengenes and associated summaries and diversity analyses were performed in QIIME.
Consistent with previous studies, the microbiota of cefoperazone-treated mice was dominated
by Lactobacillaceae (Fig 7A and S7 Table)[24–26], which comprised 39.7% (mean relative
abundance) of the total microbiota in 630Δerm infected mice. The microbiota was also
populated by Bacteroidetes, including members of the S24-7 (an uncultured commensal of
homeothermic animals[27]) (17.6%) and Paraprevotellaceae (1.2%) families. Furthermore, Fir-
micutes, including Staphylococcaceae (12.75%), other Clostridiales (7.2%), Lachnospiraceae
(4.2%), Erysipelotrichaceae (3.7%), Ruminococcaceae (2.9%), Enterococcaceae (2.2%), Turici-
bacteraceae (1.2%), and Actinobacteria including Bifidobacteriaceae (1.9%) (Fig 7A) also con-
tributed to the microbiota composition. However, animals infected with the hpdC::CT mutant
demonstrated a significant increase in microbial diversity at D7 (ANOVA p<0.05), compared
to 630Δerm infected and naïve mice (Fig 7B and S7 Table), which is also upheld with an ANO-
SIM population analysis p<0.05 (S6 Fig). Consistent with the notion that p-cresol prevents
outgrowth of Proteobacteria, the majority of the families that were only present in the hpdC
mutant infected animals were members of the Proteobacteria Phylum (S7 Table), albeit at low
abundance.
Treatment with vancomycin significantly reduced diversity of both uninfected (naïve) and
infected mice (630Δerm and hpdC::CT) (Fig 7B & 7C), resulting in a dramatic increase in the
relative representation of Lactobacillaceae, specifically the Lactobacillus genus, which consti-
tuted85% of the microbiota of all the mice examined (90% 630Δerm, 87% hpdC::CT mutant
and 85% naïve at D0R). Principle component analysis demonstrated clustering of D0 and D2
post relapse (Fig 7C). At D2R, the diversity of the microbiota remained low. At D4R, partial
recovery of the microbial diversity was observed (Fig 7A and 7B), which coincided with the
detection of C. difficile spore in faeces (Fig 6D). At D4R there were distinct differences in pop-
ulation composition in the intestinal bacteria of these animals (Fig 7D). We observed an
increase in spread on the PCA plot at D4R (Fig 7C), compared to the clustering observed at
D0R and D2R. Although the mean relative proportions of Lactobacillaceae were similar
(73.9% in 630Δerm and 72.3% in the hpdC::CT mutant infected animals), there were clear dif-
ferences in the representation of other taxa, including other Firmicutes, Proteobacteria and
Bacteroidetes (Fig 7D). In 630Δerm infected mice there was an increase in representation of
infection and d) day 4 relapse. Mann Whitney U test was used to calculate significant differences between infection with wild-type C. difficile and the
hpdC mutant marked p<0.05. Graphs were produced in GraphPad Prism 6.0.
https://doi.org/10.1371/journal.ppat.1007191.g006
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Firmicutes from the Erysipelotrichales (16.5% 630Δerm and 0.1% hpdC::CT mutant), Bacillales
(1.9% 630Δerm and 0% hpdC::CT mutant) and Clostridiales orders, and the Bacteroidetes (Fig
7D). Conversely, in the p-cresol mutant infected mice, we observed an increase in the repre-
sentation of Proteobacteria, specifically, the Gammaproteobacteria of the Pseudomonadales
(5.5% 630Δerm and 18% hpdC::CT mutant) and Enterobacteriales (0% 630Δerm, 6.75% hpdC::
CT mutant) order, and the Betaproteobacteria of the Burkholderiales order (Fig 7D). Consis-
tent with the notion that Gram-negative species were more susceptible to the effects of p-cre-
sol, Gammaproteobacteria formed 26.2% of the total microbiome in hpdC::CT infected
animals D4R, compared with 5.5% in 630Δerm infected mice (COV = 9.37, p = 0.023), suggest-
ing that p-cresol may inhibit their outgrowth following treatment with vancomycin.
Metabolic profiling of the mouse model of CDI
Our data suggest that p-cresol production by C. difficile influenced the composition of the
mouse faecal microbiota. Therefore, we investigated whether these differences resulted in an
altered biochemical profile. Stool samples collected throughout the duration of the initial
mouse infection (at day 2 (D2), 4 (D4) and 7 (D7)) and during relapse (at days 0 (D0R) and 4
(D4R)) were analysed using 1H NMR spectroscopy (Fig 8). The PCA scores plot identified
Fig 7. 16S relative abundance. The diversity of the intestinal microbiota was assessed using 16S rRNA sequencing to determine the bacterial operational taxonomic units
present during a relapse model of C. difficile infection. a) Composition of the intestinal microbiota, at the Family level, between wild type C. difficile 630Δerm and p-cresol
mutant (hpdC::CT) infected mice and the naïve control at day 7 post-infection, day 0, day 2 and day 4 post relapse. b) Box and whisker plots displaying the total number of
operational taxonomic units (OTUs) at the Family level. Statistically significant differences between the diversity of OTU’s are labelled  p<0.05 (ANOVA). c) Principle
component analysis of the microbial diversity at the Family level. Each dot represents a single mouse at a given time point, colour-coded for day 7 post-infection, and days
0, day 2 and day 4 post-relapse. d) The relative prevalence of bacterial Class in wild type C. difficile and hpdC::CT infected mice at day 7 post-infection, day 0, day 2 and day
4 post relapse. Statistical analysis was performed in Stata15 by regression analysis taking strain and bacterial class into consideration  p<0.05.
https://doi.org/10.1371/journal.ppat.1007191.g007
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biochemical variation between the faecal profiles collected D2-D7 versus D0R-D4R in the con-
trol mice and those infected with the hpdC::CT mutant. The D2-D7 samples contained greater
acetate compared to the relapse time points, and lower amounts of an unknown metabolite (δ
3.59, singlet). Vancomycin induced perturbations in the metabolic activity of the intestinal
bacteria are likely to underlie these changes[28].
The faecal profiles from mice infected with the 630Δerm strain showed similar metabolic
alterations to the control mice and those infected with the mutant strain during the initial
infection (D2-D7). However, the response was different 4 days after relapse. At D4R, the faecal
profiles from mice infected with the 630Δerm strain were more variable than the uninfected
mice and those infected with the mutant strain and were similar in composition to the initial
infection profiles (Fig 8).
Effect of p-cresol on viability and diversity of the human microbiome
We have shown that p-cresol production has deleterious effects on the outgrowth of Gram-
negative bacterial species both in vitro (Figs 1–4), and in an in vivo mouse infection model (Fig
7). Thus, we sought to determine the effect of exogenously added p-cresol on biodiversity of
the human microbiome. Healthy human stool samples were taken from donors ranging from
60–65 years old, who had not received antibiotic treatment in the last 3 months, eliminating
possible perturbations by antibiotic therapy. We measured the effect that exogenously-added
Fig 8. Metabolic profiling of the in vivo mouse relapse model of CDI. 1H NMR spectroscopy was used to investigate metabolic differences between the individually
caged mice infected with C. difficile strain 630Δerm, hpdC::CT or uninfected naïve mice. a) Principle component analysis of the metabolite diversity. Each dot represents
a single sample at a given time point. A symbol code was used for the strains 630Δerm (circle), hpdC::CT (square) and naïve mice (star), and a colour code was used to
represent the different time points, Day 2 post-infection (dark blue), Day 4 post-infection (light blue), Day 7 post-infection (green), Day 0 relapse (yellow) and Day 4
relapse (orange). b) Loading plots of the PCA model, representing the metabolites driving the distribution of the samples along principal component 1 (PC 1) and
principal component 2 (PC 2).
https://doi.org/10.1371/journal.ppat.1007191.g008
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p-cresol (at 0.1% and 0.3%) had on faecal microbiota, compared to a Phosphate Buffered Saline
(PBS) control. Differential plating revealed that the facultative anaerobes were particularly sen-
sitive to p-cresol at both 0.1% (COV = -0.61, p = 0.006) and 0.3% (COV = -1.82, p<0.001), rep-
resented by a significant reduction in viable counts (Fig 9). The Bacteroides fragilis group was
also significantly reduced after exposure to both 0.1% (COV = -1.29, p = 0.009) and 0.3%
(COV = -4.39, p<0.001) p-cresol (Fig 9). The total anaerobes and lactose-fermenting Entero-
bacteriaceae were also significantly reduced after exposure to 0.3% p-cresol (COV = -1.48,
p<0.001, COV = -2.36, p<0.001, respectively) (Fig 9). Consistent with the mouse model of
CDI, p-cresol at 0.1% had a limited effect on the survival of Lactobacillus (COV = -0.045,
p = 0.890) and Bifidobacterium species (COV = -0.100, p = 0.642). However, a significant
decrease in survival was observed for both groups when they were incubated in 0.3% p-cresol
(p<0.01). In line with our in vitro co-culture data (Fig 2), Enterococcus species present in
human faecal samples were not adversely affected by the addition of p-cresol (Fig 8), even at
the highest concentrations tested (COV = 0.48, p = 0.873).
p-cresol compromises the integrity of Gram-negative cell envelope
Given that we observed a clear distinction in the nature of species that displayed tolerance to
p-cresol, we reasoned that the cell envelope would be an obvious target for its mode of action.
Phenolic compounds that target membranes typically induce a rapid loss of low molecular
weight compounds from within the cell as a result of increased membrane permeability[29–
31]. Thus, we used the release of inorganic phosphate (Pi) as a metric for determining mem-
brane integrity in the presence of p-cresol. Initially, we compared the release of phosphate
from E. coli and C. difficile strains (630Δerm and hpdC::CT) in increasing concentrations of p-
cresol (Fig 10A). We observed a significant increase in the amount of phosphate released by E.
coli compared to C. difficile (COV = 0.868, p = 0.005). Only 16% of the total intracellular
Fig 9. Percentage survival of bacterial phyla from healthy human faecal slurry treated with p-cresol. Healthy
human donor stool samples were emulsified and treated with exogenously added p-cresol (0.1% or 0.3% v/v) for 90
minutes and the CFU counts were expressed as percentage survival relative to the CFU of the PBS control at t = 0.
Faecal emulsions were plated onto differentially selective agar to determine the survival of endogenous intestinal
bacteria to p-cresol stress. Error bars are representative of triplicate experiments. Statistical analysis was performed by
linear regression to determine the correlation between survival in 0.1% and 0.3% (v/v) p-cresol relative to the PBS
control. Significant differences are indicated with p<0.001. Error bars are Standard error of the Mean (SEM).
https://doi.org/10.1371/journal.ppat.1007191.g009
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phosphate of C. difficile was released upon contact with p-cresol. Furthermore, the hpdC::CT
mutant displayed a similar phosphate release profile to 630Δerm C. difficile (COV = 0.201,
p = 0.444), which was not significantly different (Fig 10A). This indicates that disruption of p-
cresol production had little bearing on p-cresol tolerance, under these conditions. Our data
suggests that cells can tolerate p-cresol up to a threshold level (~0.4% v/v), after which the
amount of phosphate released becomes saturated. Therefore, we selected a concentration of
0.3% (v/v) to determine phosphate release over time in a selection of Gram-positive and
Gram-negative gut bacteria. Membrane integrity was measured in the presence of p-cresol by
comparing the amount of p-cresol induced phosphate release, to the total intracellular phos-
phate, which was determined by boiling cell suspensions for 15 minutes. Fig 10 demonstrates
that species with a Gram-positive cell envelope display greater tolerance to p-cresol than
Gram-negative species, represented by significantly less phosphate release (COV = -2.478,
p<0.001), (Lactobacillales: E. faecium (p = 0.005) and L. fermentum (p = 0.003), the Bifidobac-
teriales: B. adolescentis (p = 0.01) and the Clostridiales: C. difficile (p<0.01)) corroborating pre-
vious observations. Conversely, the Gram-negative Gammaproteobacteria: P. mirabilis, E. coli
and K. oxytoca released their total intracellular pool of phosphate over the course of the assay.
P. mirabilis and K. oxytoca released 68% and 60% of their total phosphate respectively immedi-
ately upon contact with p-cresol (Fig 10B). Both species released >90% of their total phosphate
pool following 30 minutes contact with p-cresol. In contrast, no Gram-positive species ana-
lysed released their total intracellular phosphate pool over the course of the assay (Fig 10C).
However, B. adolescentis released 63% of its total phosphate at 30 minutes compared to 20%
for E. faecium, 27% for L. fermentum and 33% for C. difficile, indicating that B. adolescentis is
more sensitive to p-cresol than other Gram-positive species. Prolonged exposure to p-cresol
resulted in other Gram-positive species releasing a greater portion of their intracellular pool of
phosphate, however, the level of Pi released by C. difficile never exceeded its initial level of
release (Fig 10). In conclusion, our data demonstrate a clear correlation between bacterial cell
envelope structure and susceptibility to p-cresol.
Discussion
The indigenous microbiota has been shown to form an ecological barrier that prevents the
ingress of pathogenic bacteria such as C. difficile [32]. However, the specific components of the
intestinal microbiota that facilitate colonisation resistance are only recently becoming clear
[5–7, 25, 33–36]. Both the treatment with broad-spectrum antibiotics and the availability of
specific metabolites has been shown to play a role in the expansion of particular bacterial spe-
cies within the human microbiota [37, 38]. Here, we present compelling evidence that C. diffi-
cile may directly modify the intestinal microbiota through production of p-cresol. We
demonstrate that C. difficile displays a greater degree of tolerance to p-cresol compared to
other common intestinal species, including the Gammaproteobacteria: E. coli, K. oxytoca and
P. mirabilis, as well as the Bacteroidetes, B. thethaiotaomicron. We show that these bacterial
species are susceptible to the effects of both endogenous and exogenous p-cresol, which was
reflected in reductions of viable counts when these intestinal microbiota species were grown in
Fig 10. Phosphate release in Gram-positive and Gram-negative common gut commensal species. The release of intracellular phosphate was determined
spectroscopically (OD650) using malachite green and ammonium molybdate from: a) C. difficile 630Δerm, hpdC::CT and E. coli stationary phase cultures in various
concentrations of p-cresol. Significant differences in phosphate release compared to 630Δermwere calculated taking concentration into account using linear regression
and are marked  p<0.001. b) phosphate relapse was measured from Gram-negative common gut commensals and c) phosphate relapse was measured from Gram-
positive common gut commensals following incubation with 0.3% (v/v) p-cresol over a 90 minute time period. Red line indicates maximum phosphate release determined
by boiling a comparable cell suspension. Curves and error bars are representative of three independent replicates. Significant differences in phosphate release from the
maximum were calculated using regression analysis taking time points into consideration, significant differences are marked p<0.01, p<0.001. Error bars are SEM.
https://doi.org/10.1371/journal.ppat.1007191.g010
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competitive co-culture with C. difficile. Using a plasmid based complementation system to
restore the expression of the p-HPA decarboxylase, we have shown that p-cresol production by
C. difficile must exceed 5 mM to elicit a significant alteration in competitive growth dynamics.
We have shown that C. difficile is able to utilise all the available p-HPA supplemented in the
growth medium, which results in the production of up to 25 ±0.04 mM p-cresol in vitro (Fig
3), which is 1000-fold more than the amount of p-cresol produced from tyrosine metabolism
by other organisms cultured from the intestinal microbiota (range 0.06–1.95 μg/ml)[11].
There is evidence that p-HPA is present in the human colon and detected in healthy human
stool samples at 19 μM[15], therefore C. difficile can potentially utilise free tyrosine and p-HPA
to produce p-cresol in vivo.
We expanded our investigation of the influence of p-cresol on the growth of other bacterial
species, to identify other metabolites influencing growth. In particular, alanine, p-cresol, ace-
tate, butyrate, isobutyrate and p-HPA were the six main metabolites that were differentially
modulated in mono-culture and co-culture of C. difficile with intestinal bacteria. The abun-
dance of these metabolites in vitro was altered in the presence of the p-cresol mutant compared
to C. difficile strain 630Δerm. Acetate and butyrate are the most common end products of fer-
mentation in the gut[39]. C. difficile can use amino acids as the sole energy source via Stickland
fermentation, in which amino acid acceptors (such as glycine, proline and hydroxyproline) are
reduced in a paired metabolism with electron donors (such as leucine, isoleucine or alanine).
This can result in the conversion of alanine to acetate [40]. However, in C. difficile monocul-
ture, we did not observe an inverse association between acetate and alanine (Fig 5B), suggest-
ing that C. difficile is not utilising alanine in stickland fermentation under nutrient rich
conditions (in BHIS media). This suggests that the competitor species, may have been respon-
sible for the increased utilisation of alanine in co-culture with the p-cresol mutant and comple-
ment, where the competitor is more abundant. The reduction of the Stickland acceptors
glycine and proline in C. sticklandii and C. difficile requires two selenium dependant reduc-
tases, glycine reductase and D-proline reductase [40, 41], highlighting the importance of
selenium in growth and metabolism in C. difficile, particularly in glycine reduction and seleno-
cysteine production [40, 42]. Nutrient availability has been linked to virulence in C. difficile in
a number of different ways, via the global transcriptional regulators CodY, CcpA, PrdR and
Rex, which are involved in overlapping cellular processes including toxin production, amino
acid biosynthesis, stickland fermentation, nutrient transport, fermentation and cell membrane
components[43]. The hypervirulent C. difficile strains (RT027 and RT078) have also developed
the ability to metabolise low concentrations of trehalose, via acquisition of a single point muta-
tion in the trehalose repressor (treA), which increases virulence of these ribotypes in vivo[44].
C. difficile is also capable of utilising ethanolamine as a carbon source[45] and the ethanol-
amine genes are upregulated in vivo in the presence of B. thetaiotaomicron when animals were
fed on a standard polysaccharide diet [38].
Cysteine is involved in amino acid and energy metabolism in C. difficile [46], modulating
processes such as carbon transfer, electron transport, butyric acid and butanol production.
Cysteine results in increased levels of intracellular tyrosine [47]. Cysteine also down-regulated
4p-hydroxyphenylacetate-3-hydroxylase [48], which may reduce p-HPA availability for the p-
HPA decarboxylase and thus would decrease flux to p-cresol. Therefore, cysteine-regulated
pathways may result in increased p-cresol production. This is consistent with the notion that
the production of butyrate and p-cresol are inversely regulated.
C. difficile and other opportunistic gut bacteria have developed metabolic strategies that dif-
fer in response to environmental signals, one such strategy is the production of short chain
fatty acids [38]. Studies using a simplified gnotobiotic mouse model, have shown that succinate
produced by B. thetaiotaomicron is used by C. difficile to produce butyrate, boosting C. difficile
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titres [38]. However, in our experimental conditions (nutrient rich conditions) succinate was
detected at very low levels by 1H NMR spectroscopy. Butyrate has anti-inflammatory proper-
ties [49] and is produced by a diverse array of bacterial phyla [50]. Yet, butyrate stimulates C.
difficile toxin production in the absence of rapidly metabolised carbohydrates (e.g. glucose)
[48]. The production of butyrate from acetyl-CoA or succinate by C. difficile is suppressed by
the transcriptional regulators CcpA, CodY and Rex [51], however, if proline is limited then
alternative pathways for NAD+ regeneration are used including glycine reductase, alcohol
dehydrogenase and butyrate production from acetyl-CoA and succinate are induced [51]. We
observed lower butyrate and isobutyrate concentrations in the 630Δerm cultures (mono- and
co-cultures), which implies that C. difficile is unable to synthesise butyrate under these condi-
tions. However, we observed high butyrate and isobutyrate concentrations in co-culture with
the p-cresol mutant and complement, where the competitor is more abundant, suggesting that
the competitors are responsible for the increase in butyrate in co-culture.
Inter-C. difficile strain variation in the metabolic profiles included altered abundance of ala-
nine, isobutyrate, p-cresol and p-HPA. We observed an increase in the production of p-cresol
in monocultures and co-cultures containing the C. difficile 630Δerm and an absence of p-cresol
in all cultures with the hpdC::CT mutant, consistent with the inability of the mutant to synthe-
sise p-cresol (Fig 5B). The complement produced an intermediate amount of p-cresol (Figs 5B
and S3) and therefore clustered between the wild type and mutant in the PCA plot, suggesting
that p-cresol and p-HPA were the main metabolites driving separation between C. difficile
strains. This observation was corroborated when p-cresol production was increased in co-cul-
ture by increasing the supply of p-HPA, which resulted in a decrease in the competitor relative
to wild-type C. difficile.
In this study, we present evidence that p-cresol production by C. difficile prevents out-
growth of discrete taxa of bacteria in vitro and that p-cresol production may modulate compo-
sition of the mouse microbiota. Our data showed clear differences in the composition of the
microbiota of mice infected with the p-cresol mutant compared with the 630Δerm strain pre-
and post-relapse in our infection model (Fig 7). Recovery of the microbial community to its
pre-dysbiotic state is often a slow process and, consequently, susceptibility to C. difficile coloni-
sation can be increased for weeks and even months following cessation of antibiotics[52, 53].
Both the 630Δerm and the hpdC::CT mutant successfully colonised mice at the initial infection
stage. However, we observed increased microbial diversity in hpdC::CT infected mice, at day 7
post-infection. This diversity was largely driven by OTUs that each constituted <0.1% of the
total microbiota. Despite relatively low abundance of these OTUs, they could have important
consequences for the microbial ecosystem. These Families include Corynebacteriaceae, Pro-
pionibacteriaceae (both Actinobacteria), Bradyrhizobiaceae, Burkholderiaceae, Comamonada-
ceae, Oxalobacteraecea, Rhodocyclaceae, Bdellovibrionaceae and Enterobacteriaceae (all
Proteobacteria). Consistent with the notion that p-cresol prevents outgrowth of Proteobac-
teria, the majority of these Families were members of the Proteobacteria Phylum. Vancomycin
treatment reduced microbial diversity, altered the metabolic content of the stool samples, and
resulted in a microbiome that was susceptible to relapse with C. difficile. The remaining micro-
bial community was dominated by Lactobacillaceae (consistent with previous publications
[24]), which was insufficient to restore colonisation resistance following vancomycin with-
drawal. Upon cessation of vancomycin treatment, we observed an expansion of microbial
diversity (D2R and D4R). There were clear differences in microbiota composition at D4R
between animals infected with the p-cresol mutant and 630Δerm C. difficile. The second most
abundant class present in the microbiome of hpdC mutant-infected mice was Gammaproteo-
bacteria (26.2%). In contrast, the second most abundant class in animals infected with
630Δerm C. difficile was the Erysipelotrichia (16.5%). Other studies have shown that without
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FMT, dysbiosis is maintained in mice with two main OTUs, Lactobacillus and Turicibacter
(Erysipelotrichia order)[24, 35], which we observed in the 630Δerm infected mice, but not
mice infected with the p-cresol mutant. We have shown in vitro that Gammaproteobacteria,
including K. oxytoca, E. coli and P. mirabilis are more sensitive to p-cresol than C. difficile,
while Gram-positive bacteria from the Lactobacillales family are more resistant to p-cresol.
This is particularly pertinent as the majority of the microbiota post-vancomycin treatment was
comprised almost exclusively of Lactobacillus and an increased expansion of the Gammapro-
teobacteria was only seen in p-cresol mutant-infected mice. The faecal metabolic profiles from
all animals post-vancomycin treatment (D0R) were clearly distinct from those collected post-
infection (D2, D4 and D7; Fig 7). However, the metabolic profiles of mice infected with the
630Δerm strain 4 days after withdrawal of vancomycin were more variable than those infected
with the mutant strain. The 630Δerm infected mice also had a metabolic signature more simi-
lar in composition to those samples collected post-infection (D2, D4 and D7). This suggests
that the biomolecular perturbations following re-establishment of infection with 630Δerm
were more closely related to those observed with the initial infection. In contrast, the hpdC::
CT-infected mice had profiles more closely related to the uninfected mice.
To complement the in vitro co-culture assay and mouse model of CDI we assessed the effect
of exogenous p-cresol on the human microbiota using ex vivo healthy human faecal samples.
We observed a reduction in the number of viable total anaerobes, facultative anaerobes and
lactose fermenting enterobacteriacea (LFE). The LFE are comprised of the Gammaproteobac-
teria E. coli, Klebsiella spp, Enterobacteria spp, Citrobacter spp and Serratia spp. This observation
corroborates previous findings that demonstrate a significantly reduced viability of Gram-neg-
ative bacteria by in vitro growth kinetic analysis, competitive co-culture and in a mouse model
of CDI. In contrast, the Gram-positive bacteria isolated from the ex vivo healthy human faecal
samples (Bifidobacteriaceae, Lactobacillales and Enterococcaceae) were consistently less sensi-
tive to p-cresol in the assays we performed.
In this study, we have shown that C. difficile displays a greater degree of tolerance to p-cresol
when compared to a selection of other common intestinal bacterial species. Our data suggest a
clear distinction between the fundamental properties of the organisms susceptible to the p-cre-
sol, whereby Gram-positive species displayed greater tolerance than Gram-negative species.
We demonstrate that p-cresol affects the integrity of surface barriers resulting in a concentra-
tion-dependant leakage of small molecules such as phosphate. Similar effects have been
observed with m-cresol and chloro-cresol on bacterial cell membranes[29]. p-cresol was
recently shown to inhibit proliferation of colonic epithelial cells and induce necrotic leakage of
protons through the inner mitochondrial membrane[54]. Pseudomonas putida strain P8,
which has the capacity to degrade p-cresol, modifies its fatty acid composition by increasing
the abundance of 9-trans hexadeconoic acid and decreasing the abundance of 9-cishexadeco-
noic acid when grown in the presence of sub-lethal concentrations of phenol[30, 55, 56]. Previ-
ous work has demonstrated that sublethal concentrations of phenolics, including p-cresol,
resulted in an increase in the degree of saturation of cell membrane lipids, which is thought to
counteract the increase in membrane fluidity [30, 57].
In conclusion, we demonstrate that the production of p-cresol by C. difficile alters the com-
position and recovery of diversity in the intestinal microbiota. A p-cresol deficient mutant has
a reduced ability to compete with other intestinal microbiota species in vitro. We have shown
that the effect of p-cresol is more detrimental to the growth of Gram-negative bacteria, differ-
entially inhibiting proliferation of various bacterial Phyla. Exposure to p-cresol resulted in
release of cellular phosphate, suggesting that it disrupts cell envelope integrity. This study pro-
vides evidence that p-cresol production by C. difficile provides it with a competitive survival
advantage over other intestinal bacterial species.
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Materials and methods
Bacterial strains and culture
C. difficile strains 630Δerm[58] and hpdC::CT[22] have been previously described. The intesti-
nal microbiota species used in the study were obtained from Mark Wilcox and Simon Baines
at the University of Leeds isolated from a gut soup model of CDI (S1 Table). All bacteria were
cultured in pre-reduced Brain Heart Infusion (BHI) (Oxoid), supplemented with 0.5% (w/v)
yeast extract (BHIS) and 0.05% (w/v) L-cysteine (Sigma), at 37˚C and under anaerobic condi-
tions. For growth rate analysis, our collection of gut bacteria was grown in 100 ml tissue cul-
ture flasks with shaking at 50 rpm, 37˚C and under anaerobic conditions. Pre-reduced growth
media was supplemented with 0.1%, 0.05% and 0.01% (v/v) p-cresol as indicated. OD595 was
determined every hour for 8 hours with a final reading at 24 hours, growth curves were per-
formed in triplicate. A p-cresol complement strain (hpdC::CT::phpdCA) was made, using an
inducible plasmid based system derived from pRPF185[59] (S2 Table). The hpdCA genes were
PCR amplified and cloned downstream of a tetracycline inducible promoter (ptet) in pRPF185
[59] to produce the plasmid phpdCA. This was then conjugated into the hpdC::CT mutant to
create a complement[60]. This was performed alongside an empty plasmid pLDempty, which
was derived from pRPF185[59], to contain the ptet promoter, but without a gene (S2 Table).
This was transferred into C. difficile using competent E.coli CA434[60] into both 630Δerm and
hpdC::CT mutant as controls. Linear regression analysis was performed using Stata15; data
was transformed using Log10 to approximate a normal distribution. The data was mined to
determine if there was a significant difference in; a) strains, the growth of all bacteria strain
compared to the reference strain C. difficile strain 630, b) p-cresol concentration compared to
the BHIS untreated control, c) the Gram-negative bacteria compared to the Gram-positive
bacteria. The COV indicates whether the growth is higher (positive number) or lower (nega-
tive number) than the reference and the p-value indicates the probability, a minimum cut off
of p<0.05 was used throughout for significance (S3 Table).
Minimum inhibitory concentrations (MIC) assays. All experiments were performed in
pre-reduced media. Primary C. difficile strains were grown in BHIS broth until OD595 0.3 on a
shaking platform at 50 rpm, then were diluted 1/100 into 24-well plates containing pre-
reduced BHIS media supplemented with vancomycin or cefoperazone at a range of 1–256 μg/
ml. These plates were incubated on a shaking platform at 50 rpm for 24 hours under anaerobic
conditions at 37˚C before OD595 was used to measure growth compared to an un-inoculated
blank control. The MIC was taken as the lowest concentration to completely inhibit visible
growth. The MICs were calculated as the mean of the three independent biological and techni-
cal replicates. There is no significant difference in the MICs between the C. difficile strains
(630Δerm, hpdC::CT, hpdC::CT_phpdCA) (S6 Table).
Growth rate analysis. All experiments were performed in pre-reduced media. Growth
rates of C. difficile strains (630Δerm, hpdC::CT and hpdC::CT::phpdCA) and intestinal species (E.
coli, K. oxytoca, E. faecium and L. fermentum), were grown for 8 hours in BHIS media to com-
pare growth rates, by measuring OD595. CFUs were calculated at OD 0.5 for each of the strains
tested (S4 Table). The effect of anhydrotetracycline (ATC) was assessed by growing overnight
primary cultures of C. difficile strains (630Δerm, hpdC::CT and hpdC::CT::phpdCA) in 10 ml
BHIS supplemented with 0, 100 and 250ng/ml ATC. OD595 was measured and each strain
diluted to an OD595 0.5, and used to inoculate secondary cultures at OD595 0.05 into pre-
reduced BHIS, supplemented with ATC as outlined above. The OD595 was determined every
hour for 8 hours with a final reading at 24 hours, growth curves were performed in triplicate.
Co-culture with extrinsic p-cresol. Under anaerobic conditions, an overnight culture of
C. difficile and a gut competitor were normalised to a starting OD595 of 0.5 and were used to
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inoculate 1/10 into 15 ml of BHI + 0.05% (w/v) L-cysteine supplemented with 0.05% (v/v) p-
cresol, which was grown with shaking (50 rpm) for 24 hours. The total number of colony
forming units (CFU) was determined by plating serial dilutions on non-selective BHI + 0.05%
(w/v) L-cysteine. The total number of C. difficile was determined by plating serial dilutions on
BHIS + 0.05% (w/v) L-cysteine and cycloserine/cefoxitin supplement (BHIS CC) (Sigma),
which could, in turn, be used to determine the total number of CFU for the competitor. Serial
dilutions were plated in triplicate and an average of the three technical replicates was used to
determine total CFU. Each experiment was performed in triplicate. Linear regression analysis
was performed in Stata15 on the log10 of the CFU as outlined above.
Competitive co-culture with intrinsic p-cresol. Under anaerobic conditions, individual
overnight cultures of C. difficile and an intestinal competitor were grown in 10 ml of BHI
+ 0.05% (w/v) L-cysteine supplemented with 100 ng/ml or 250 ng/ml ATC (to induce expres-
sion of hpdCA expressed in trans in the complement strain). Individual monocultures were
normalised to a starting optical density (OD600) of 0.5, and were inoculated 1/10 into BHIS
broth supplemented with 0.05% L-cysteine (w/v) and either 0.1, 0.2 or 0.3% p-HPA (w/v) (6.5
mM, 13.1 mM and 19.7 mM, respectively), these monocultures were grown until C. difficile
reached an OD 0.5–0.6 (~7 hours). The competitor was back diluted to an OD595 0.5 and inoc-
ulated 1:10 into the C. difficile culture, to create a competitive co-culture. These co-cultures
were grown anaerobically, shaking (50 rpm) for 24 hours and were plated onto both BHIS
non-selective plates and BHIS CC plates. CFU counts of both C. difficile and the competitor
were determined and processed as outlined above. Each experiment was performed in tripli-
cate and Linear regression analysis was performed in Stata15 on the log10 of the CFU as out-
lined above, statistically significant differences were observed p<0.05.
Metabolic profiling of supernatants
Culture supernatant from mono-culture and co-culture experiments in media supplemented
with 0.1 and 0.2% (v/v) p-HPA were filter sterilised. Samples were diluted into 400 μL of phos-
phate buffer (pH 7.4, 100% D2O, 3 mM of NaN3, 1 mM of 3-(trimethyl -silyl)-[2,2,3,3-
2H4]-
propionic acid (TSP) for the chemical shift reference at δ0.0) according a 1:2 ratio. Samples
were transferred to 5 -mm tubes for 1H nuclear magnetic resonance (NMR) spectroscopic
analysis, which was performed on a Bruker 600 MHz spectrometer (Bruker Biospin, Karlsruhe,
Germany) at 300K (26.85˚). The parameters of the acquisition were as previously reported for
urine[61]. Each spectrum was acquired with 4 dummy scans followed by 32 scans. Spectra
were automatically phased, baseline corrected and calibrated to the internal standard (TSP)
using Topspin (Bruker Biospin, Karlsruhe, Germany). The processed spectral data was
imported into Matlab (version R2014a, The Mathworks Inc.). The region δ4.84–4.76 was
removed to eliminate the residual water signal. Principal Components Analysis (PCA) was
performed using pareto scaling, due to the significant intensity of the acetate signal (δ 1.92, sin-
gle. Based on the PCA loadings, spectral peaks contributing to the principal components were
integrated using an in-house script. These metabolite peak integrals were used to construct a
clustergram in Matlab using the clustergram script.
Sporulation assays
Primary cultures were inoculated from a single colony of C. difficile strains (630Δerm, hpdC::
CT, hpdC::CtphpdCA) into pre-reduced BHIS broth and grown to an OD595 0.3 on a shaking
platform at 50 rpm. These were inoculated 1/100 into pre-equilibrated BHIS broth which was
incubated statically for 72 h under anaerobic conditions at 37˚C. Total counts (vegetative cells
and spores) and spore counts were then determined using CFU assays in 1X PBS (1/10
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dilutions from 0 to -5). All dilutions were plated onto BHIS plates supplemented with 1% taur-
ocholate. The spore counts were performed by heat inactivation of vegetative cells at 65˚C for
20 minutes, these were then serially diluted and CFU counts determined on BHIS taurocholate
plates. All experiments were performed with duplicate technical replicates and triplicate bio-
logical replicates. All data was analyzed in Excel, plotted in GraphPad Prism 7 and statistical
analysis was performed in Stata15 using regression analysis p<0.05 were considered signifi-
cantly different (S5 Fig).
Mouse relapse model of CDI
Female C57BL/6 mice (Charles River; 7–9 weeks old) were kept in independently ventilated
cages under sterile conditions. As outlined by Theriot et al.[62], mice were treated with cefo-
perazone in the drinking water (50 mg/litre) for 10 days to disrupt their normal microflora,
rested for two days, before they were infected with 104 C. difficile spores by oral gavage. After
28 days, vancomycin was added to the drinking water for 7 consecutive days (400 mg/litre) to
induce relapse of CDI. Fresh faecal samples from individually infected mice were collected
throughout the time course to be utilised for determining the C. difficile load, 16S rRNA
sequencing of the microflora and metabolite profiling by 1H spectroscopy. Stool samples were
plated onto C. difficile selective plates to determine the bacterial load (CFU/g). Statistical analy-
sis was performed using a one tailed Mann Whitney U test, p<0.05 were considered signifi-
cantly different.
Ethics statement
All animal procedures were performed at Royal Holloway in accordance with the Home Office
project license PPL 70/8276, that enables work to be conducted under the UK “Animal (Scien-
tific Procedures) Act 1986”. This work was approved by the Royal Holloway, University of
London Ethics Committee.
Healthy human donor faecal samples were collected and processed using different healthy
donors who had not received antibiotic treatment in the preceding 3 months in accordance
with the University of Hertfordshire Ethics committee guidelines and approval (UH Ethics
Approval Number: aLMS/SF/UH/00103). All donors provided informed written consent.
Microbiota analysis
DNA was extracted from faecal samples using a combined method based on phenol:chloro-
form:isoamyl alcohol extraction, ethanol precipitation and FastDNA SPIN kit for soil (MPBio-
medicals). Briefly, an equal mass of faecal material was suspended in 50 mM Tris-HCl pH7.5,
10 mM EDTA, homogenised and bacterial cells were lysed using a FastPrep-24 Classic Instru-
ment (MPBiomedicals). Nucleic acid was extracted using a standard phenol:chloroform:isoa-
myl alcohol procedure, followed by ethanol precipitation and was suspended in nuclease free
dH2O. Faecal DNA was subsequently purified using the DNA binding matrix from the Fas-
tDNA SPIN kit for soil with minor modifications of the manufacturer’s instructions. Briefly,
DNA samples were added to sodium phosphate buffer, MT buffer and protein precipitation
solution supplied in the kit and this was added directly to the binding matrix. DNA was subse-
quently purified according to the manufacturer’s instructions and eluted in DNase-free water.
Library preparations for the MiSeq were performed as outlined in Rosser et al[63]. Briefly, an
amplification step was used to add Illumina compatible adaptors, with a unique 12 bp individ-
ual barcodes for each sample, with an extra pad and linker sequence. The V5-7 regions of the
16S rRNA genes were then amplified using 785F: 5´-GGATTAGATACCCBRGTAGTC-3´,
1175R: 5 ´-ACGTCRTCCCCDCCTTCCTC-3´ primers, where the reverse primer (1175R)
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contained the individual error-corrected barcode: 25 μl reactions were comprised of 1x Mol-
zym PCR buffer, 0.025 μM Moltaq (Molzym), 200 μM dNTPs (Bioline), 0.4 μM forward and
reverse primer, 2 μl DNA and nuclease free water (Bioline)[63]. Cycling parameters for each
reaction were 94˚C x 3 min, then 30 cycles of 94˚C x 30 s, 60˚C x 40 s, 72˚C x 90 s and final
extension at 72˚C for 10 min. Samples were purified and normalised using a SeqPrep normali-
sation plate kit (Invitrogen), and quantified using a Qubit2.0 (Life technologies), and further
purified using 0.6 X Agencourt AMPure Beads (Beckman Coulter), a selection of samples were
run on an Agilent high sensitivity DNA chip (Agilent Technologies), samples were quantified
again using a Qubit 2.0 (Life Technologies), and were pooled in equimolar solution, then
diluted to a 2 nM library, with 10% PhiX control and loaded into the MiSeq run cartridge in
accordance with the manufacturer’s instructions (Illumina). The MiSeq runs produced 250 bp
paired end reads, with a 12 bp individual index for each sample. The sequence reads generated
were de-multiplexed and quality filtered using QIIME (version 1.9.1 [64]) following the stan-
dard pipeline to assign Illumina reads to operational taxonomic units (OTUs) using the
Greengenes database [65]). Associated summaries and diversity analyses were also performed
in QIIME. Subsequent analyses were performed in R [66] and visualised with ggplot2 [67]. We
selected families to include in our 16S plots (Fig 7A) if they had mean proportion of greater
than 1% in any of the 12 day/type phenotype combinations. Box plots (Fig 7B) and PCA (Fig
7C) were calculated from the full 16S rRNA sequence dataset at the family level. ANOSIM
analysis was used to identify variation in species abundance and composition between strains
630Δerm and hpdC::CT, as well as between time points D7, D0R, D2R and D4R. Significant
differences were indicated with a circle p<0.001.
Metabolic profiling of mouse faecal samples
Faecal samples were defrosted and mixed with 400 μL of phosphate buffer (pH 7.4, 100% D2O,
3 mM of NaN3, 1 mM of 3-(trimethyl-silyl)-[2,2,3,3-
2H4]-propionic acid (TSP) for the chemi-
cal shift reference at δ0.0) and Zirconium beads (0.45 g ±0.1). The samples were vortexed and
then homogenised with a FastPrep-24 Classic Instrument (MP BIOMEDICALS) (30 sec per
cycle, speed 6.0, 2 cycles). After a centrifugation (13,000 xg, 15 min), 180 μL of the supernatants
were collected and transferred in 3-mm tubes for 1H nuclear magnetic resonance (NMR) spec-
troscopic analysis, which was performed on a Bruker 600 MHz spectrometer (Bruker Biospin,
Karlsruhe, Germany) at 300K (26.85˚). The parameters of the acquisition were as previously
reported for urine[61]. 4 dummy scans followed per 64 scans were acquired for each spectrum
which were then imported into Matlab (version R2014a, The Mathworks Inc.). The region
δ4.82–4.76 was removed to eliminate residual water signal. All spectra were normalised
according probabilistic quotient method and automatically aligned. Principal Components
Analysis (PCA) was performed with mean-centring and Pareto scaling.
HPLC
Frozen culture supernatants were defrosted on ice and were mixed in a 1:1 ratio with metha-
nol: water, transferred to HPLC tubes and processed immediately by HPLC. Mouse faecal
samples were defrosted, and added to a 2 ml screw cap tube containing 2 mm beads. These
were weighed before and after addition of the faecal sample. To these, 400 μl 1:1 methanol:
water was added to the pellet, then ribolysed twice using a FastPrep-24 Classic Instrument at
speed 6.0 m/s for 30 sec. Tubes were transferred to ice and centrifuged at 14000 xg for 20 min-
utes. 250 μl of the supernatant was transferred to a clean sterile HPLC tube and were trans-
ferred immediately for HPLC. Each experiment was performed in triplicate. All HPLC
equipment, software, solvents, columns and vials were from Thermo Fisher Scientific, UK.
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Separations were performed utilising an Acclaim 120, C18, 5 μm Analytical (4.6 x 150 mm)
and the mobile phase consisting of ammonium formate (10 mM, pH 2.7) and menthol (v/v;
40:60) at a flow rate of 2 ml/min. p-HPA and p-cresol were detected by the photo-diode array
detector (UV-PDA; DAD 3000) set at 280 nm. Peak identity was confirmed by measuring the
retention time, spiking the sample with commercially available p-HPA and p-cresol and deter-
mination of absorbance spectra using the UV-PDA. A calibration curve of each compound
was generated by Chromeleon (Dionex software) using known amounts of the reference stan-
dards (0–100 mg/ml) in methanol/water (v/v; 1:1) injected onto the column to determine the
amount in the samples. The lower limit of detection was determined for p-HPA to be 0.03 mg/
ml, for p-cresol to be 0.02 mg/ml. The concentration in mM was determined in Excel, using
the molecular weight of the compounds and the quantity in mg/ml. The data was analysed in
GraphPad Prism7 and statistical analysis was performed in Stata15 using linear regression
analysis.
Cultivatable human bacteria following p-cresol stress
Healthy human donor faecal samples were collected and processed using three different
healthy donors who had not received antibiotic treatment in the preceding 3 months. Faecal
samples (5 g) were emulsified in sterile pre-reduced PBS (50 ml) and faecal material was coarse
filtered by passing the 10% emulsion through sterile muslin cloth to remove larger particle
matter and leave a bacterial suspension. Faecal emulsions were incubated for 1 hour and 30
minutes in 1X PBS, or PBS containing 0.1% (v/v) p-cresol or 0.3% (v/v) p-cresol. Samples were
then sedimented by centrifugation at 14000 x g for 5 minutes and the supernatant were
removed. Pellets were resuspended in 1 ml 1X PBS and viable counts (CFU/ml) were per-
formed on differentially selective agar, both anaerobically and aerobically. Each experiment
was performed in triplicate. Serial 10-fold dilutions of re-suspended faecal emulsions in sterile
pre-reduced peptone water were inoculated onto: fastidious anaerobe agar (total anaerobes),
nutrient agar (total facultative anaerobes), kanamycin aesculin azide agar (Enterococci), LAM-
VAB agar (Lactobacilli), Beeren’s agar (Bifidobacteria), MacConkey agar number 3 (lactose-
fermenting Enterobacteriaceae), Bacteroides bile aesculin agar (B. fragilis group), and total via-
ble counts were determined in triplicate, and normalised to the starting CFU.
Phosphate release
Release of cellular phosphate was investigated using a Colorimetric Phosphate Assay Kit
(Abcam). The assay involved treating samples with ammonium molybdate and malachite
green which forms a chromogenic complex with phosphate ions which can be detected at a
wavelength of 650 nm. An overnight culture of each bacterial strain was sedimented by centri-
fugation and re-suspended in Tris-buffered saline (TBS, 50 mM Tris-HCl pH7.5, 150 mM
NaCl) and subsequently washed two further times to remove traces of the growth medium.
OD595 was determined and cell suspensions were normalised to an OD595 of 1.0. Five hundred
microliter aliquots of cell suspension were sedimented by centrifugation and re-suspended in
either TBS alone or TBS + p-cresol. Cell suspensions were incubated for the indicated time,
cells were sedimented and 30 μl of supernatant was removed and added to 170 μl H2O and
30 μl ammonium molybdate and malachite green reagent. Absorbance was read at 650 nm in a
96-well microtitre plate reader. Phosphate release was determined by normalising the optical
density from cell suspensions incubated with p-cresol against cell suspensions that were incu-
bated with TBS alone. The assay was performed under anaerobic conditions except for spec-
trophotometry and sedimentation steps, for which tubes and flasks were sealed with parafilm
to prevent oxygen infiltration. The maximum intracellular phosphate pool was determined by
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boiling a 500 μl cell suspension (OD595 1.0) for 15 minutes. All assays were performed in
triplicate.
Supporting information
S1 Fig. Differential growth rates in BHIS. Growth curves were performed in BHIS media
under anaerobic conditions to determine the differential growth rate between C. difficile
strains 630Δerm, hpdC::CT and the complemented mutant (hpdC::CT::phpdC-A and the intes-
tinal microbiota species a) E. coli and K. oxytoca, and b) E. faecium and L. fermentum. The
time, in minutes, that each strain reached OD595 0.5 is indicated by the purple hash line. C)
The growth rate of C. difficile strains (630Δerm, hpdC::CT and complement hpdC::CT::
phpdC-A) was assessed in BHIS supplemented with a range of anhydrotetracycline concentra-
tions (0, 100 and 250 ng/ml). All experiments were performed in triplicate. Error bars are Stan-
dard Error of Mean (SEM).
(TIF)
S2 Fig. Modulating p-cresol production and the effect on competitive co-culture. Relative
fitness of C. difficile 630Δerm, hpdC::CT and hpdC::CT complement in competitive co-culture
for 24 hours with gut commensal species was performed in media supplemented with p-HPA
(0.3% v/v). Expression of the hpdCA in trans from a plasmid-borne tetracycline-inducible pro-
moter in the hpdC::CT background was evaluated by varying the concentration of anhydrote-
tracycline (100 and 250 ng/ml). The relative fitness of the C. difficile strains (wild-type, p-cresol
mutant and complement) was compared in competition with a) E.coli and b) K. oxytoca. The
relative proportion of each strain was expressed as a percentage of the total CFU count. Error
bars are representative of three independent replicates. Regression analysis was used to deter-
mine significant differences in growth taking strain into consideration and marked  p<0.01
and p<0.001. c&d) The concentration of p-cresol produced in the co-cultures quantified by
HPLC. e&f) The concentration of p-HPA remaining in the media after the co-cultures was
quantified by HPLC. Regression analysis was used to determine significant differences in p-
cresol production and p-HPA utilisation compared to 630Δerm  p<0.001. Error bars are
SEM.
(TIF)
S3 Fig. Detection of p-cresol by 1H NMR. a) 1H NMR spectra doublet of pHPA (δ6.867ppm)
and p-cresol (δ6.831ppm), with C. difficile strains highlighted in different colours 630Δerm
(black), hpdC::CT (red) and the complemented mutant hpdC::CT::phpdC-A (blue). Each line
represents an individual 1H NMR spectrum of the culture supernatants. The arrows on the
right indicate the differences between the p-cresol levels produced from either 0.1% pHPA or
0.2% pHPA.
(TIF)
S4 Fig. Comparison of the metabolite profiles in medium supplemented with 0.1% and
0.2% pHPA. 1H NMR spectroscopy was used to determine the metabolite profiles of co-cul-
ture samples in media containing 0.1% and 0.2% p-HPA. a) PCA demonstrating metabolic
variation across the profiles in media containing 0.1% or 0.2% (v/v) p-HPA. b) Loading plots
of the PCA model showing the metabolites driving the groupings along principal component 1
(PC1) and principal component 2 (PC2).
(TIF)
S5 Fig. Sporulation assay of C. difficile strains. The sporulation frequency of strains
630Δerm, hpdC::CT and the complemented mutant hpdC::CT::phpdC-A, were determine in
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BHIS media grown for 72 hours in BHIS broth. a) total cell counts were enumerated on BHIS
plates containing 0.1% taurocholate and spore counts were determined by heat inactivation of
vegetative cells at 65˚C for 20 minutes before enumerated on BHIS taurocholates plates. b) per-
centage sporulation was calculated as a proportion of the total cell counts for each strain
respectively. Statistical analysis was performed in Stata15 using linear regression and p<0.05
was considered a statistically significant difference. n/s indicates no significant differences.
(TIF)
S6 Fig. ANOSIM population analysis of the microbiota. ANOSIM was performed to identify
differences in bacterial population between 630Δerm and hpdC::CT infected animals across the
experiment as well as at given time points, D7, D0R, D2R and D4R. Significant differences are
indicated with a circle p<0.001.
(TIF)
S1 Table. Gut intestinal microbes used in this study.
(XLSX)
S2 Table. Strains, plasmids and primers.
(XLSX)
S3 Table. Statistical analysis of growth curves in BHIS with exogenous p-cresol. The top
table shows the output of a Linear Regression analysis to compare the growth of a particular
strain of bacteria, at a given concentration of p-cresol against the reference strain, C. difficile.
Grey shading indicates analyses where the p<0.05. The bottom table indicates the relative
effect of p-cresol concentration on the growth of a particular strain, relative to the growth rate
in BHIS as a reference. This analysis was performed in Stata15 using linear regression, p<0.05
are shaded grey. COV is the co-efficient of variance of the test from the reference.
(XLSX)
S4 Table. Colony counts for different bacterial strains at OD 0.5.
(XLSX)
S5 Table. Colony counts for extrinsic p-cresol co-culture experiments. CFU/ml was deter-
mined each bacterial species grown in co-culture in the presence or absence of extrinsic p-cresol.
(XLSX)
S6 Table. Minimum inhibitory concentrations of vancomycin and cefoperazone.
(XLSX)
S7 Table. Diversity of the microbiome at Day 7. A table demonstrating the relative abun-
dance of families comprising the faecal microbiome at day 7 for the wild-type infected, hpdC::
CT infected and naïve mice.
(XLSX)
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